Deborah M.F. van den Buijs, MD1; Floris S. van den Brink, MD, PhD2,3; Adriaan Wilgenhof, MD4; Carlo Zivelonghi, MD4; Niels Verouden, MD, PhD1; Paul Knaapen, MD, PhD1; Krischan D. Sjauw, MD, PhD3; Paul Vermeersch, MD, PhD4; Alex Nap, MD, PhD1
Deborah M.F. van den Buijs, MD1; Flo...
Patients with complex coronary artery disease, concomitant cardiac disease, and multiple comorbidities are addressed as complex higher-risk indicated patients (CHIPs). Selecting a revascularization strategy in this population remains...
Patients with complex coronary artery disease, concomitant cardiac disease, and multiple comorbidities are addressed as complex higher-risk indicated patients (CHIPs). Selecting a revascularization strategy in this population remains...